Prognostic marker analysis in pediatric posterior fossa ependymomas.
Publication
, Journal Article
McLendon, RE; Lipp, E; Gururangan, S; Fuchs, H; Zagzag, D; Herndon, J; Healy, P
Published in: Neuro Oncol
July 2014
NELL2 expression has been shown to identify patients with posterior fossa ependymomas (PFEp) that exhibit prolonged survivals. We analyzed expression NELL2; KI-67; Tenascin C; CD34; VEGF; and CA IX as well as vascular density against post-operative survival (Progression Free and Overall Survival; PFS, OS) in 31 patients under the age of 22 years.
Duke Scholars
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
July 2014
Volume
16 Suppl 3
Start / End Page
iii27
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
McLendon, R. E., Lipp, E., Gururangan, S., Fuchs, H., Zagzag, D., Herndon, J., & Healy, P. (2014). Prognostic marker analysis in pediatric posterior fossa ependymomas. Neuro Oncol, 16 Suppl 3, iii27. https://doi.org/10.1093/neuonc/nou208.17
McLendon, R. E., E. Lipp, S. Gururangan, H. Fuchs, D. Zagzag, J. Herndon, and P. Healy. “Prognostic marker analysis in pediatric posterior fossa ependymomas.” Neuro Oncol 16 Suppl 3 (July 2014): iii27. https://doi.org/10.1093/neuonc/nou208.17.
McLendon RE, Lipp E, Gururangan S, Fuchs H, Zagzag D, Herndon J, et al. Prognostic marker analysis in pediatric posterior fossa ependymomas. Neuro Oncol. 2014 Jul;16 Suppl 3:iii27.
McLendon, R. E., et al. “Prognostic marker analysis in pediatric posterior fossa ependymomas.” Neuro Oncol, vol. 16 Suppl 3, July 2014, p. iii27. Pubmed, doi:10.1093/neuonc/nou208.17.
McLendon RE, Lipp E, Gururangan S, Fuchs H, Zagzag D, Herndon J, Healy P. Prognostic marker analysis in pediatric posterior fossa ependymomas. Neuro Oncol. 2014 Jul;16 Suppl 3:iii27.
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
July 2014
Volume
16 Suppl 3
Start / End Page
iii27
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences